PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27002827-11	2017	Prior administration of cilostamide reversed the anorectic and body weight-reducing effects as well as stimulatory effect of insulin on hypothalamic Pomc mRNA levels.	cilostamide	24-35	pro-opiomelanocortin-alpha	Mus musculus	149-153	
27002827-13	2017	CONCLUSION: Insulin induction of hypothalamic PDE3B activity and the reversal of the anorectic and body weight-reducing effects and stimulatory effect of insulin on hypothalamic Pomc gene expression by cilostamide suggest that activation of PDE3B is a novel mechanism of insulin signaling in the hypothalamus.	cilostamide	202-213	pro-opiomelanocortin-alpha	Mus musculus	178-182	
22001576-4	2011	Recently, we have demonstrated that cilostamide reversed the leptin-induced increase in proopiomelanocortin (POMC) gene expression in the hypothalamus.	cilostamide	36-47	pro-opiomelanocortin-alpha	Mus musculus	88-107	
22001576-4	2011	Recently, we have demonstrated that cilostamide reversed the leptin-induced increase in proopiomelanocortin (POMC) gene expression in the hypothalamus.	cilostamide	36-47	pro-opiomelanocortin-alpha	Mus musculus	109-113